Furosemide Tablets Solicitation

SOL #: SPE2D2-26-R-0005Pre-Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Last Updated
Jun 10, 2026
3
Response Deadline
Jun 4, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) Troop Support is soliciting offers for a Firm-Fixed-Price Requirements Contract to establish a national supply source for Furosemide Tablets. This unrestricted acquisition aims to provide Furosemide 20 MG, 40 MG, and 80 MG tablets to DLA, Department of Veterans Affairs (VA), Bureau of Prisons (BoP), and Indian Health Service (IHS) customers. Proposals are due June 18, 2026, at 3:00 PM EST.

Scope of Work

The solicitation requires the provision of Furosemide tablets in various counts:

  • Furosemide 20 MG Tablets: 90-count and 1000-count bottles.
  • Furosemide 40 MG Tablets: 90-count and 1000-count bottles.
  • Furosemide 80 MG Tablets: 500-count bottle/box. All products must be FDA approved with a therapeutic equivalence (TE) Code "A" and include National Drug Codes (NDC). Key technical requirements include compatibility with automated dispensing units, child-proof closures for unit-of-use packaging, and bar code labeling (GS1-128 or HIBCC standards) displaying lot number and expiration date. Offerors must also comply with the Drug Supply Chain Security Act (DSCSA) and ensure manufacturing facilities have acceptable cGMP status with the FDA.

Contract & Timeline

  • Contract Type: Firm-fixed-price requirements contract.
  • Period of Performance: One base year with four option years, not exceeding five years.
  • Set-Aside: Unrestricted.
  • NAICS Code: 325412 (Drugs And Biologicals), with a size standard of 1,300 employees. Large businesses must submit a subcontracting plan.
  • Contract Price Effective Date: No more than 60 calendar days after award.
  • Contract Performance Date: 45 calendar days after award (ready to fill orders).
  • Submission Deadline: June 18, 2026, 3:00 PM EST.
  • Original Solicitation Published: April 21, 2026.

Submission & Evaluation

Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS). The evaluation criteria will be Lowest Price Technically Acceptable (LPTA), assessing proposals on Technical Requirements, Past Performance, and the lowest evaluated aggregate price across all line items for the base and option years. Discussions may be held to clarify proposals.

Additional Notes

Offerors are permitted to engage with Pharmaceutical Prime Vendor (PPV) contractors regarding business-to-business agreements prior to submission. The Government retains the right to modify ordering sites/activities and notes that the price paid to a PPV contractor may be adjusted by distribution fees. Primary Contact: Nancy Fernandez (nancy.fernandez@dla.mil, 445-737-0713).

People

Points of Contact

Jason C. WraySECONDARY

Files

Files

Download
Download

Versions

Version 5
Pre-Solicitation
Posted: Jun 10, 2026
View
Version 4Viewing
Pre-Solicitation
Posted: Jun 3, 2026
Version 3
Pre-Solicitation
Posted: May 19, 2026
View
Version 2
Pre-Solicitation
Posted: Apr 21, 2026
View
Version 1
Pre-Solicitation
Posted: Mar 12, 2026
View